KLOW is a research blend combining GHK-Cu (50 mg), BPC-157 (10 mg), TB-500 (10 mg) and KPV (10 mg) in a single lyophilised vial (80 mg total). It extends the GLOW combination with KPV, the C-terminal tripeptide fragment of alpha-MSH, for comparative peptide-signalling, tissue-model and inflammatory-pathway research that requires all four materials in one vial.
KLOW is a research blend combining GHK-Cu (50 mg), BPC-157 (10 mg), TB-500 (10 mg) and KPV (10 mg) in a single lyophilised vial (80 mg total). It extends the GLOW combination with KPV, the C-terminal tripeptide fragment of alpha-MSH, for comparative peptide-signalling, tissue-model and inflammatory-pathway research that requires all four materials in one vial. It is supplied strictly as a research-use compound for qualified laboratory work and is not for human or animal use.
